
Merck invests $1B in Delaware drug manufacturing facility
Dive Brief: Merck is constructing a $1 billion drug manufacturing facility in Wilmington, Delaware, as part of its commitment to investment and growth in the United States. The company on Tuesday said it broke ground on its 470,000-square-foot biologics …